Phospholow
Natural health product licensed in Canada
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 80003343
- Status
- Active licence
- Licence date
- 4 May 2007
- Revision date
- 3 February 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Cellulose, microcristalline, Stéarate de magnésium, Béhénate de glycéryle, Croscarmellose de sodium, Dioxyde de silicium colloïdal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 70 years | 1 Comprimé | 2 Tous les jours |
| Adultes (enceintes et/ou allaitantes) | minimum: 14 years ; maximum: 50 years | 1 Comprimé | 2 Tous les jours |
| Enfants | minimum: 1 year | 1 Comprimé | 2 Tous les jours |
| Adultes | maximum: 70 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Helps in the maintenance of bones and teeth, especially in infancy and childhoood. Helps to prevent bone resorption and osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid using two (2) hours prior to or until four (4) hours after taking other medications.
Source
Official Health Canada record, licence 80003343
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.